KKOYY vs BIO
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
KKOYY · KESKO OYJ UNSP ADR EACH REPR 0.5 ORD REP B SHARES$20.88 ▲ 25.38%
BIO · Bio-Rad Laboratories$381.57 ▲ 3.41%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- KKOYY +100.3%
- BIO +24.1%
Head to head
| Metric | KKOYY | BIO |
|---|---|---|
| Price | $20.88 | $381.57 |
| Change today | ▲ 25.38% | ▲ 3.41% |
| Market cap | $10.28B | $10.26B |
| Return, 3 months | +69.2% | +7.6% |
| Return, year to date | +90.2% | +25.9% |
| Return, 1 year | +101.8% | +24.9% |
| P/E (TTM) | 33.1 | 10.1 |
| P/B | 5.2 | 1.3 |
| P/E percentile vs own 5y | – | 93rd |
| Dividend yield | 2.47% | – |
| Revenue growth (YoY, latest qtr) | – | -0.1% |
| Net profit growth (YoY) | – | +16.9% |
| Gross margin | – | 51.9% |
| Operating margin | – | 8.7% |
| Net margin | – | 8.6% |
| Return on equity | – | 3.1% |
| Analyst target vs. price | – | +2.2% |
| Analyst buy share | – | 100% |
| RSI (14) | 95 | 56 |
| 30-day volatility | 72.9% | 34.8% |
| Max drawdown, 1 year | -15.5% | -28.1% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- KKOYY is the largest of the group by market value.
- KKOYY has returned the most over the past year.
- BIO carries the lowest trailing P/E.
- BIO has been the calmest stock over the last 30 days.